Gene manufacturing platforms, patient-centric formulations, contract services, packaging innovations, and sterile filling lines are in the spotlight at CPHI Milan 2026.
|Articles|June 2, 2017
- Pharmaceutical Technology-06-02-2017
- Volume 41
- Issue 6
Control Box Connects Lab Sensors and Pumps
The Easy Control Box from Mettler Toledo connects any lab sensor and pump to make real-time measurement and controlled dosing available to non-experts.
The Easy Control Box (ECB) from Mettler Toledo connects any lab sensor and pump to make real-time measurement and controlled dosing available to non-experts. The ECB combines data from all sensors in a single-experiment, allowing researchers to compare experimental results for chemical process development.
Pumps and balances connect to the ECB for automated pre-programmed gravimetric dosing. Linking temperature with dosing control enables reagent addition to stop in dangerous exothermic situations. Experiments can run unattended, allowing more experiments to be performed under safe conditions.
Articles in this issue
over 9 years ago
Planetary Dispersers with PLC Recipe Controlsover 9 years ago
Paperless Recorder Shortens Sampling Intervalsover 9 years ago
Sterilizer Uses Pulsed Light Technologyover 9 years ago
Boosting Bioproduction Workflows with Automation Technologiesover 9 years ago
Decoding Serialization Regulationsover 9 years ago
Synchronizing Anticounterfeiting Effortsover 9 years ago
New and Updated Laboratory Equipment Optimize Efficiencyover 9 years ago
Understanding Dissolution Testingover 9 years ago
Particle Size Reduction for Investigational New DrugsRelated to this article
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.
Episode 1, Part 3 of PharmTech AI Pulse Check covers why INTerpath-001's AI isn't ChatGPT and names pharma manufacturing's biggest AI governance gaps.
Michael Levy, senior vice president, Digital & Innovation, USP, explains the digital supply chain in a preview of his upcoming CPHI Milan panel presentation, The Next Phase of Pharma Supply Chains.
FDA approves tavapadon, first D1/D5 agonist, validating AbbVie's $8.7B Cerevel deal and an October five-strength oral tablet launch.
Richard Jaenisch weighs how FDA's new NAM rule could reshape preclinical testing and what CMC teams should do now, on Manufacturing Intelligence.
In a preview of their panel discussion at AAPS PharmSci 360 2026, Alfred Rumondor, PhD, AbbVie, and Swita Singh, PhD, Bristol Myers Squibb, discuss the implementation of risk-based approaches for CMC.
Merck licenses SciBrunch's preclinical KRAS G12D inhibitor for $2.13B, raising tech transfer and scale-up questions for oral cancer drug development.